-
1 Comment
Huakang Biomedical Holdings Company Limited is currently in a long term uptrend where the price is trading 24.1% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Huakang Biomedical Holdings Company Limited's total revenue rose by 11.5% to $8M since the same quarter in the previous year.
Its net income has dropped by 150.6% to $-5M since the same quarter in the previous year.
Finally, its free cash flow fell by 15.8% to $-4M since the same quarter in the previous year.
Based on the above factors, Huakang Biomedical Holdings Company Limited gets an overall score of 3/5.
ISIN | KYG4644W1069 |
---|---|
CurrencyCode | HKD |
Exchange | HK |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
PE Ratio | None |
---|---|
Target Price | None |
Market Cap | 175M |
Beta | 0.48 |
Dividend Yield | None |
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China, Hong Kong, and Canada. The company provides male fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; and auxiliary reproductive supplies and equipment. It also offers healthcare products and supplements under the Nutronic brand through its websites, including nutronic.ca and nutronic.hk; offline channels, such as Eugenebaby and green price shops; and e-commerce platforms comprising Tmall, JD.com, Amazon, HKTVmall, Eugenebaby, etc. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8622.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025